Evommune, Inc.（EVMN）内部人交易：高管与董事近期交易
过去 18 个月，共有 19 位内部人为 Evommune, Inc.（EVMN）报告了 59 笔 Form 4 交易（最近一笔 2026-07-10）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-10 | Carver Kyle | Chief Financial Officer | 买入 | 1,000 | $13,260 |
| 2026-07-08 | KIRSCH ARTHUR S | 董事 | 买入 | 10,000 | $133,000 |
| 2026-06-24 | Pena Luis C. | President & CEO | 卖出 | 7,438 | $168,917 |
| 2026-06-24 | Drew Janice Suzann | Chief of Dev. Operations | 买入 | 3,839 | $14,742 |
| 2026-06-24 | Drew Janice Suzann | Chief of Dev. Operations | 买入 | 16,161 | $48,321 |
| 2026-06-24 | Drew Janice Suzann | Chief of Dev. Operations | 卖出 | 20,000 | $452,600 |
| 2026-06-24 | Patel Jeegar Pravinkumar | Chief Scientific Officer | 买入 | 1,488 | $5,714 |
| 2026-06-24 | Patel Jeegar Pravinkumar | Chief Scientific Officer | 卖出 | 1,488 | $33,480 |
| 2026-06-03 | Cohen David E | 董事 | 卖出 | 5,456 | $110,266 |
| 2026-06-03 | Cohen David E | 董事 | 卖出 | 600 | $12,828 |
| 2026-06-03 | Pena Luis C. | President & CEO | 卖出 | 16,787 | $381,736 |
| 2026-06-03 | Patel Jeegar Pravinkumar | Chief Scientific Officer | 买入 | 13,512 | $51,886 |
| 2026-06-03 | Patel Jeegar Pravinkumar | Chief Scientific Officer | 卖出 | 16,687 | $379,462 |
| 2026-06-01 | Carver Kyle | Chief Financial Officer | 买入 | 15,000 | $44,850 |
| 2026-06-01 | Carver Kyle | Chief Financial Officer | 卖出 | 18,175 | $415,117 |
| 2026-06-01 | Moss Gregory S. | Chief Business & Legal Officer | 买入 | 14,223 | $24,321 |
| 2026-06-01 | Moss Gregory S. | Chief Business & Legal Officer | 卖出 | 14,223 | $324,711 |
| 2026-02-19 | LSP 7 Cooperative UA | 董事 | 买入 | 358,680 | $10.0M |
| 2026-02-18 | Verduyn-van Weegen Felice Isabel | 董事 | 买入 | 358,680 | $10.0M |
| 2026-02-17 | RA Capital Healthcare Fund LP | 董事 | 买入 | 35,868 | $1,000,000 |
| 2026-02-17 | RA CAPITAL MANAGEMENT, L.P. | 董事 | 买入 | 35,868 | $1,000,000 |
| 2026-02-17 | Kolchinsky Peter | 董事 | 买入 | 35,868 | $1,000,000 |
| 2026-02-17 | Shah Rajeev M. | 董事 | 买入 | 35,868 | $1,000,000 |
| 2026-02-17 | RA Capital Nexus Fund III, L.P. | 董事 | 买入 | 35,868 | $1,000,000 |
| 2025-12-22 | Hopfner Robert Lorne | 董事 | 买入 | 1,000 | $17,350 |
来源：SEC Form 4 申报文件 · 截至 2026-07-10